New technology could be game changer for people living with Type 1 diabetes
There's a new high-tech tool that could be a game-changer for people with Type 1 diabetes. Yale Principal Investigator and Associate Professor in Pediatrics (Endocrinology), Jennifer Sherr, discusses the Omnipod 5, which monitors insulin levels through a sensor on the skin, then sends the insulin directly through the patch as needed.Source: WNYT.com
Major Funding Award Supports Yale Efforts to Address Maternal Health Inequities
A team of Yale researchers, working collaboratively with Yale New Haven Hospital, community partners and two regional hospitals, is exploring ways to improve health outcomes among pregnant and postpartum women in priority populations that have been historically underserved and experience systemic racism. A $18 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) will support the study.
Yale Geneticist With Rare Disease to Build Pediatric Cell Atlas of Skeletal Muscle
A $3 million grant from the Chan Zuckerberg Initiative, awarded to a team of researchers led by Monkol Lek, PhD, assistant professor of genetics at Yale, will support Lek and his team in creating a Pediatric Cell Atlas of Skeletal Muscle — a roadmap of healthy skeletal cells and how they change at four key age group milestones between the ages of zero and 18 years.
Fetal Alcohol Exposure Data Underscore Need for Public Health Interventions
While alcohol consumption during pregnancy may result in harm to developing embryos and fetuses, a new study led by the Yale School of Public health finds that a significant number of pregnancies that result in live birth still involve alcohol exposure.Source: Yale News
Finally, Another Effective Drug for Kids and Teens with Type 2 Diabetes
Type 2 diabetes is on the rise in children and teens, but treatment options for pediatric patients have remained more limited than those available to adults. In its first pediatric trial, a new drug — already used by type 2 diabetic adults — has proven effective for blood sugar control in children and teens with type 2 diabetes.
Yale New Haven Becomes First in Connecticut to Perform Pediatric Heart Transplants
Yale New Haven Children’s Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.
Child deaths from opioids nearly tripled in recent years, says Yale study
Close to 9,000 children and teens in the United States died from opioid poisonings over the last two decades, representing a nearly three-fold increase in mortality rates, Yale researchers said. These findings illustrate how the opioid epidemic continues to evolve and harm children even as efforts to confront the crisis through treatment and limits on opioid prescribing ramp up, they said.
Child Abuse Expert John M. Leventhal, MD, Awarded Leffell Prize for Clinical Excellence
John M. Leventhal, MD, has received the 2018 David J. Leffell Prize for Clinical Excellence in recognition of his exceptional achievements and his dedication to working with abused, neglected and sexually abused children.
Marietta Vázquez Appointed Vice Chair for Diversity for Pediatrics
The Department of Pediatrics is pleased to announce the appointment of Marietta Vázquez, MD, associate professor of pediatrics, as vice chair for diversity, equity and inclusion. Vazquez is a pediatric infectious diseases specialist at Yale School of Medicine.
Dyslexia gene variants tied to consonant use across populations
In a new study of languages spoken in 43 different populations worldwide, Yale School of Medicine researchers and their colleagues identified variants of a dyslexia gene that correlate with consonant use, establishing a role for genetics in language differences between populations.
Opportunities to vaccinate young women against HPV missed at alarming rate
en aged 18-26 who were eligible to receive Human Papilloma Virus (HPV) vaccine have missed at least one opportunity to receive the vaccine during a visit to an obstetrics and gynecology clinic, Yale researchers report. This study also confirms previous research showing racial disparities in vaccination for HPV: Women who identify as black are 61% more likely have had a missed opportunity than women who identify as white. These findings are published in the American Journal of Obstetrics and Gynecology. HPV is a well-known cause of pre-cancerous cervical lesions, which, if untreated, could develop into cervical cancer. Immunization against HPV has been shown to be safe and effective in preventing these pre-cancerous lesions. The two-dose HPV vaccine is recommended for administration to It is recommended that girls ages 11-12 receive the two-dose HPV vaccine, and that those through age 26 receive the three-dose vaccination for “catch-up.”
Pediatric cancer providers give medical marijuana a cautious thumbs-up
New research by Yale Cancer Center (YCC) researchers shows a majority of pediatric cancer providers endorse the potential use of medical marijuana for children with advanced cancer, although providers who are legally eligible to certify its use are more cautious than those who aren’t. The findings also show clinicians would prefer to see much stronger clinical evidence that marijuana treatments can help in relieving symptoms, such as nausea and pain.
Lifespan Research: Impact of Childhood Disease on Adult Health
YCCI’s renewed CTSA grant award allows Yale to continue its leadership in cutting-edge areas of research. One such novel initiative under the grant renewal is Diseases Across the Lifespan, which will explore the rising field of lifespan research — a new approach to examining the ways in which diseases that commonly strike adults have their roots in infancy and early childhood.
Many high school kids graduate to cigarettes after e-cigarette use
High school students who use e-cigarettes are more likely to smoke cigarettes in subsequent years, according to a new Yale University study published Dec. 4 in the journal Pediatrics. Those who smoke cigarettes, by contrast, are no more likely than non-smokers to use e-cigarettes over time, the three-year survey of Connecticut high school students shows.